Mosquito Borne Diseases Market Report 2025

This Mosquito Borne Diseases market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The mosquito borne diseases market size has grown strongly in recent years. It will grow from $3.06 billion in 2024 to $3.31 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth during the historic period can be attributed to the increasing prevalence of malaria and dengue, rising global temperatures, insufficient public health infrastructure, urbanization and population growth, and heightened healthcare awareness.

The mosquito borne diseases market size is expected to see strong growth in the next few years. It will grow to $4.51 billion in 2029 at a compound annual growth rate (CAGR) of 8%. The growth expected in the forecast period is driven by rising investments in vector control programs, a stronger focus on healthcare infrastructure, an increase in travel and tourism to endemic regions, the emergence of drug-resistant mosquito strains, and government efforts aimed at disease eradication. Key trends in this period include the development of insecticide-treated bed nets, the introduction of rapid diagnostic test kits, advancements in vector control methods, technological innovations, and the creation of advanced diagnostic tools.

The rise in international travel is expected to drive the growth of the mosquito-borne diseases market. This surge in travel is fueled by the increased demand for leisure, business, and reunions post-pandemic, alongside enhanced accessibility and improved travel infrastructure. International travel plays a role in the spread of mosquito-borne diseases by exposing travelers to mosquito habitats, facilitating the movement of disease-carrying mosquitoes, and complicating effective vector control measures. For example, in September 2024, the UN Tourism, a Spain-based tourism agency, reported approximately 1.1 billion international tourist arrivals (overnight visitors) from January to September 2024, marking an 11% increase compared to the same period in 2023. As a result, the surge in international travel is contributing to the growth of the mosquito-borne diseases market.

Companies operating in the mosquito-borne diseases market are focusing on developing innovative products, such as advanced mosquito repellents, to improve protection against diseases such as malaria, dengue, and Zika. Advanced mosquito repellents include products that incorporate long-lasting, effective ingredients or technologies, such as microencapsulation, natural compounds, or wearable devices, to offer enhanced protection. For instance, in March 2023, Mortein, an Australia-based household insecticide brand, launched the Mortein Smart+, an advanced liquid vaporizer designed to provide protection against mosquitoes. This product offers two hours of residual protection even after being turned off, addressing the growing threat of mosquito-borne diseases with faster and more effective repellency. The launch demonstrates Mortein’s commitment to providing reliable solutions for families, particularly in the fight against mosquito-borne illnesses.

In February 2024, Kao Corporation, a Japan-based chemicals company, formed a partnership with Earth Corporation to address mosquito-borne diseases in Thailand. Together, they introduced the ARS Mos Shooter, an eco-friendly spray formulated with advanced surfactant technology and lemongrass essential oil to impede mosquito flight. This initiative aims to reduce the incidence of dengue fever by encouraging community involvement and raising public health awareness. Earth Corporation is a Japan-based company that produces household products and insecticides and is actively involved in addressing mosquito-borne infectious diseases.

Major players in the mosquito borne diseases market are Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Syngenta, Takeda Pharmaceuticals, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Serum Institute of India Pvt. Ltd., Orkin Inc., RTI International, Emergent BioSolutions, Valneva SE, BioCryst Pharmaceuticals Inc., Bharat Biotech, Vector Control International, Clarke Environmental Mosquito Management, Inovio Pharmaceuticals, and Oxitec Ltd.

North America was the largest region in the mosquito borne diseases market in 2024. Latin America is expected to be the fastest-growing region in the forecast period. The regions covered in mosquito borne diseases report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the mosquito borne diseases market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Mosquito-borne diseases are a category of infectious illnesses caused by parasites, viruses, and bacteria transmitted to humans through the bites of infected female mosquitoes. These diseases pose significant health risks, contributing to increased morbidity and mortality rates, and highlighting the need for effective prevention and control strategies in both endemic and non-endemic regions worldwide.

The primary types of mosquito-borne diseases include malaria, dengue, yellow fever, West Nile virus, chikungunya, Zika virus, and others. Malaria is a mosquito-borne illness caused by Plasmodium parasites, transmitted to humans through the bites of infected female Anopheles mosquitoes. It involves various treatment options, such as medication, vaccination, vector control methods, immunotherapy, supportive care, and more, serving a wide range of end users, including hospitals, clinics, diagnostic centers, research institutes, government organizations, and non-governmental organizations.

The mosquito-borne diseases market research report is one of a series of new reports that provides mosquito-borne diseases market statistics, including mosquito-borne diseases industry global market size, regional shares, competitors with a mosquito-borne diseases market share, detailed mosquito-borne diseases market segments, market trends and opportunities, and any further data you may need to thrive in the mosquito-borne diseases industry. This mosquito-borne disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The mosquito borne diseases market consists of sales of insecticide-treated bed nets, antimalarial medications, adult mosquito control products, diagnostic kits, and protective clothing. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.